MedTrace Logo

Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia

NCT00665197 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2011-10-13

No results posted yet for this study

Summary

Hypothesis: In the management of advanced oesophageal cancer, to determine if a shorter regime of external beam radiotherapy (using higher daily doses, and combined with intraluminal high dose rate brachytherapy) is not inferior in the palliation of dysphagia than a more protracted course of external beam radiotherapy (using lower daily doses and combined with equal intraluminal high dose rate brachytherapy).

Conditions

  • Esophageal Cancer

Interventions

RADIATION

Protracted Course Radiotherapy

External Beam Radiation 30 Gy in 10 fractions

RADIATION

Short Course Radiotherapy

External Beam Radiation 20 Gy in 5 fractions

Sponsors & Collaborators

  • International Atomic Energy Agency

    lead OTHER_GOV

Principal Investigators

  • Eduardo Rosenblatt, MD · International Atomic Energy Agency

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Canada
  • China
  • Croatia
  • India
  • Pakistan
  • South Africa
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00665197 on ClinicalTrials.gov